{"gao_id": "GAO-15-390", "published": "2015-07-08T12:00:00Z", "released": "2015-08-10T08:00:00Z", "summary": "", "title": "Medicaid: Additional Reporting May Help CMS Oversee Prescription-Drug Fraud Controls", "topics": ["Claims processing", "Health Care", "Controlled substances", "Erroneous payments", "Beneficiaries", "Utilization review", "Federal spending", "Fraud", "Physicians", "Prescription drugs", "Databases", "Data integrity", "Program abuses", "Raw materials", "Reporting requirements", "Medicaid", "Health care programs", "Pharmaceutical industry"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-15-390", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-15-390-highlights.pdf"}, {"title": "Full Report (64 pages)", "url": "https://www.gao.gov/assets/gao-15-390.pdf"}, {"title": "Accessible PDF (79 pages)", "url": "https://www.gao.gov/assets/680/671814.pdf"}]}